Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
107.40    -1.00 (-0.92%)
Bid:
107.00
Ask:
107.40
Spread: 0.40 (0.374%)
Market Cap: £176.08m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Director/PDMR Shareholding

3 Jan 2012 16:51

RNS Number : 9322U
Yule Catto & Co PLC
03 January 2012
Β 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

Β 

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

Β 

(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

Β 

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

Β 

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Β Please complete all relevant boxes in block capital letters.Β 

1. Name of the issuer

Β 

YULE CATTO & CO PLC

Β 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2R; (ii) a disclosure made in accordance with LR 9.8.6R(1); or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006)

Β 

(i)

Β 

3. Name of person discharging managerial responsibilities/director

Β 

DR ALEXANDER DOBBIE

Β 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

NOTIFICATION RELATES TO DR A A DOBBIE AND HIS WIFE - MRS M S DOBBIE

Β 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

Β 

NOTIICATION IS IN RESPECT OF THE BENEFICAL HOLDINGS OF DR DOBBIE AND HIS WIFE.

Β 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

ORDINARY SHARES OF 10P EACH

Β 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Β 

TD DIRECT INVESTING NOMINEES (EUROPE) LIMITED

Β 

8. State the nature of the transaction

Β 

SALE AND PURCHASE OF SHARES

Β 

9. Number of shares, debentures or financial instruments relating to shares acquired

Β 

16,000 SHARES

Β 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

0.005%

Β 

11. Number of shares, debentures or financial instruments relating to shares disposed

Β 

16,000 SHARES

Β 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

Β 

0.005%

Β 

13. Price per share or value of transaction

Β 

16,000 SHARES SOLD BY DR A A DOBBIE AT Β£1.6414 PER SHARE

3,000 SHARES BOUGHT BY DR A A DOBBIE AT Β£1.6487 PER SHARE

13,000 SHARES BOUGHT BY MRS M S DOBBIE AT Β£1.6546 PER SHARE

Β 

14. Date and place of transaction

Β 

31 DECEMBER 2011

Β 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

TOTAL HOLDIG UNCHANGED AT 114,853 SHARES; 0.034% OF ISSUED SHARE CAPITAL

Β 

16. Date issuer informed of transaction

Β 

3 JANUARY 2012

Β 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxesΒ 

17 Date of grant

Β 

Β 

18. Period during which or date on which it can be exercised

Β 

Β 

19. Total amount paid (if any) for grant of the option

Β 

Β 

20. Description of shares or debentures involved (class and number)

Β 

Β 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Β 

Β 

22. Total number of shares or debentures over which options held following notification

Β 

Β 

23. Any additional information

Β 

Β 

24. Name of contact and telephone number for queries

Β 

RICHARD ATKINSON

TEL: 01279 459512

Β 

Name and signature of duly authorised officer of issuer responsible for making notification

Β 

RICHARD ATKINSON - COMPANY SECRETARY

Β 

Date of notification

3 JANUARY 2012

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSBKNDQABKDADK
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.